
pmid: 18024097
Mesenchymal stromal cells (MSC) are multipotent cells that can be derived from many different organs and tissues. They have been demonstrated to play a role in tissue repair and regeneration in both preclinical and clinical studies. They also have remarkable immunosuppressive properties. We describe their application in settings that include the cardiovascular, central nervous, gastrointestinal, renal, orthopaedic and haematopoietic systems. Manufacturing of MSC for clinical trials is also discussed. Since tissue matching between MSC donor and recipient does not appear to be required, MSC may be the first cell type able to be used as an "off-the-shelf" therapeutic product.
Multipotent Stem Cells, Mesenchymal stromal cells, Mesenchymal Stem Cells, Therapeutic applications, Review, Mesenchymal Stem Cell Transplantation, 730102 Immune system and allergy, C1, Mesenchymal stem cells, Humans, Regeneration, Stromal Cells, 320205 Transplantation Immunology
Multipotent Stem Cells, Mesenchymal stromal cells, Mesenchymal Stem Cells, Therapeutic applications, Review, Mesenchymal Stem Cell Transplantation, 730102 Immune system and allergy, C1, Mesenchymal stem cells, Humans, Regeneration, Stromal Cells, 320205 Transplantation Immunology
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 223 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 1% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 1% |
